Evaluation of left ventricular systolic function in patients with different types of ischemic heart disease by two-dimensional speckle tracking imaging

Table 2 Comparison of blood biochemical indexes in obstructive CAD group, CMD group and control group

Parameters	obstructive CAD group (n = 67)	CMD group (n = 67)	control group (n = 108)	P value
TC, mmol/L	3.87 ± 0.90	4.25 ± 0.84	4.44 ± 0.95	0.000**
TG, mmol/L	1.47 (1.21, 2.34)	1.26 (0.96, 1.63)	1.40 (1.04, 2.05)	0.037*
HDL-C, mmol/L	0.96 ± 0.18	1.21 ± 0.31	1.18 ± 0.29	0.000**
LDL-C, mmol/L	2.25 ± 0.73	2.44 ± 0.69	2.56 ± 0.78	0.040*
UA, μmol/L	351.1 ± 71.9	312.7 ± 75.2	317.9 ± 70.6	0.004**
Cr, μmol/L	87.6 ± 17.1	74.2 ± 16.0	77.4 ± 13.2	0.000**
FGB, mmol/L	6.1 ± 1.9	5.5 ± 1.3	5.4 ± 1.0	0.007**
HbA1c, %	6.4 ± 1.2	6.0 ± 0.8	6.0 ± 0.8	0.029*
hsCRP, mg/dl	1.10 (0.48, 1.96)	0.67 (0.48, 2.47)	1.15 (0.47, 2.17)	0.839
NTpro-BNP, pg/ml	60.3 (31.4, 119.5)	81.1 (36.7, 156.9)	50.0 (30.0, 87.3)	0.038*

TC total cholesterol, TG triglyceride, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, UA uric acid, Cr creatinine, FBG fasting blood glucose, HbA1C glycosylated hemoglobin, hsCRP high-sensitivity C-reactive protein, NT-proBNP N-terminal B-type brain natriuretic peptide precursor. The distribution of TG, hsCRP and BNP was non-normal distribution. The data were expressed as median (quartile 1, quartile 3), i.e. M (p25, p75). *: P < 0.05; **: P < 0.01

ISSN: 1749-8090